Log In
Print this Print this

BromSite (ISV-303)

  Manage Alerts
Collapse Summary General Information
Company Sun Pharmaceutical Industries Ltd.
DescriptionLow-dose bromfenac, an NSAID, delivered via InSite's DuraSite sustained delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat inflammation and eye pain; Treat ocular inflammation and pain after cataract surgery
Regulatory Designation
PartnerNicox S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today